Mirati Theraps Drug Patent Portfolio
Mirati Theraps owns 1 orange book drug protected by 1 US patent Given below is the list of Mirati Theraps's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10689377 | KRas G12C inhibitors | 17 May, 2037 | Active |
Latest Legal Activities on Mirati Theraps's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mirati Theraps.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail O.P. Petition Decision | 21 Mar, 2024 | US10689377 |
|
Email Notification
Critical
| 21 Mar, 2024 | US10689377 |
| Mail-Record Petition Decision of Granted to Make Entity Status large | 19 Mar, 2024 | US10689377 |
| Record Petition Decision of Granted to Make Entity Status large | 18 Mar, 2024 | US10689377 |
| O.P. Petition Decision | 16 Mar, 2024 | US10689377 |
| Petition Entered | 09 Jan, 2024 | US10689377 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 09 Jan, 2024 | US10689377 |
| Payment of Maintenance Fee under 1.28(c) | 09 Jan, 2024 | US10689377 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 26 Dec, 2023 | US10689377 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 24 Jul, 2023 | US10689377 |
|
Email Notification
Critical
| 24 Jul, 2023 | US10689377 |
|
Electronic Review
Critical
| 24 Jul, 2023 | US10689377 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 21 Jan, 2022 | US10689377 |
|
Email Notification
Critical
| 21 Jan, 2022 | US10689377 |
|
Correspondence Address Change
Critical
| 19 Jan, 2022 | US10689377 |
Mirati Theraps's Family Patents
Mirati Theraps drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 23.3% of its total global patent coverage. Click
below to unlock the full patent family tree.
Mirati Theraps Drug List
Given below is the complete list of Mirati Theraps's drugs and the patents protecting them.
1. Krazati
Krazati is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10689377 | KRas G12C inhibitors |
17 May, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Krazati's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List